Daratumumab treatment increases the risk of upper respiratory tract infections in multiple myeloma : A systematic review and meta-analysis
Purpose This systematic review and meta-analysis was conducted to investigate the risk of upper respiratory tract infection in multiple myeloma patients undergoing antineoplastic therapy with the anti-CD38 monoclonal antibody Daratumumab. Methods PubMed, CINAHL, and Scopus databases were searched fo...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Södertörns högskola, Miljövetenskap
2020
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:sh:diva-41517 |